ライフサイエンスコーパス: crossover trial

1 t and 435 assigned placebo, including 101 in crossover trials).

2 nd, placebo-controlled, response-conditional crossover trial.

3 d, double-blind, placebo-controlled, partial crossover trial.

4 placebo-controlled, double-blind, randomized crossover trial.

5 n coinfected persons in a placebo-controlled crossover trial.

6 domized, double-blinded, placebo-controlled, crossover trial.

7 were enrolled in a randomized, prospective, crossover trial.

8 r placebo for 1 month each in a double-blind crossover trial.

9 o a hospital research unit for 24 hours in a crossover trial.

10 rolled in a double-blind, placebo-controlled crossover trial.

11 ing was assessed in a double-blind, 3-period crossover trial.

12 and 60% oxygen/40% nitrogen in a randomized, crossover trial.

13 olled in a double-blind, placebo-controlled, crossover trial.

14 o 56 years, were enrolled in a double-blind, crossover trial.

15 andomized, double-blind, placebo-controlled, crossover trial.

16 randomised double-blind, placebo-controlled crossover trial.

17 andomized to each of three pacing modes in a crossover trial.

18 ulticenter, double-blind, placebo-controlled crossover trial.

19 We did a randomised, double-blind, crossover trial.

20 acebo in a 6-week, randomized, double blind, crossover trial.

21 ets (50% of dietary energy) in a randomized, crossover trial.

22 ubjects with stable angina in a double-blind crossover trial.

23 d and 18 (81.8%) completed the double-blind, crossover trial.

24 s) in an open-label, multicenter, randomized crossover trial.

25 ot using HRT, participated in a double-blind crossover trial.

26 ults in a 2x4-week double-blind, randomised, crossover trial.

27 in a postprandial randomised, double blind, crossover trial.

28 randomized, placebo-controlled, double-blind crossover trial.

29 n was a randomized, double-blind, controlled crossover trial.

30 signed in a double blind placebo-controlled, crossover trial.

31 andomized, double-blind, placebo-controlled, crossover trial.

32 andomized, double-masked, placebo-controlled crossover trial.

33 lthy volunteers in a randomized, controlled, crossover trial.

34 h elevated depressive affect in a randomized crossover trial.

35 randomized double-blind, placebo-controlled, crossover trial.

36 ner-blinded, randomized, placebo-controlled, crossover trial.

37 year, community-based, randomized controlled crossover trial.

38 double-blind, placebo-controlled, two-period crossover trial.

39 A randomised double blind crossover trial.

40 1 hour in a randomized, double-blind, 3-way crossover trial.

41 tes during exercise recovery in young men.In crossover trials, 10 resistance-trained men [aged 21 +/-

42 In a double-blind randomized four-leg crossover trial, 14 individuals wore a removable applian

43 mmatory responses.In a randomized controlled crossover trial, 17 participants [body mass index (in kg

44 In a randomized, balanced, crossover trial, 18 healthy male participants consumed t

45 In a randomized, placebo-controlled crossover trial, 19 ragweed allergen-sensitive subjects

46 In this blinded, placebo-controlled crossover trial, 20 patients with TRD were randomly assi

47 In a multicenter randomized crossover trial, 21 patients with type 2 diabetes (age 5

48 multicenter, randomized, single-blind, 2-arm crossover trial, 240 patients underwent 2 single photon

49 nter, randomized, placebo (PLAC)-controlled, crossover trial, 45 patients with nondiabetic CKD stages

50 In a randomized, crossover trial, 48 children with CF were allocated cons

51 ntrolled, double-blind, randomized, 3-period crossover trial (8 wk of treatment, 6 wk of washout) tha

52 In a double-blind crossover trial, 80 patients with rheumatoid arthritis (

53 In an open randomized crossover trial, 98 patients with coronary heart disease

54 In a randomized crossover trial, a diet containing 300 g shrimp/d, which

55 and 40% oxygen/60% nitrogen in a randomized crossover trial, again controlling for tidal volume.

56 This was a cluster-randomized, multiple-crossover trial among 974 adults admitted to a tertiary

57 ble blind, placebo-controlled NIMH inpatient crossover trial and examined for association with risk f

58 .90, a sample size of 24 is required for the crossover trial and over 150 subjects for the parallel d

59 male volunteers were randomly assigned in a crossover trial, and after a washout period, all subject

60 Studies 1 and 2 were randomized controlled crossover trials, and study 3 was a parallel study.

61 le-blind, placebo-controlled, single-centre, crossover trial assessed the effectiveness of an oral ne

62 randomized, double-blind, placebo-controlled crossover trial assessing a TRPV1 antagonist (SB-705498)

63 a double-blind placebo-controlled randomized crossover trial assessing the effects of high versus low

64 Double-masked, randomized crossover trial at 13 study sites, including the Peli la

65 We did a pragmatic, cluster-randomised, crossover trial at nine hospitals in the southeastern US

66 randomised, double-blind, placebo-controlled crossover trial at ten centres in Canada, the Czech Repu

67 sed controlled, non-inferiority, four-period crossover trial at three sites in Shanghai, China, and o

68 In a double-blind, placebo-controlled crossover trial, challenges involving two food color add

69 Pragmatic, cluster randomized crossover trial comparing 12 months of SOD with 12 month

70 rom healthy adults enrolled in a randomized, crossover trial comparing a high-PA diet to a low-PA/hig

71 double-blind, placebo-controlled, randomized crossover trial comparing albuterol inhalation aerosol w

72 a pivotal Phase 3, randomized, double-blind, crossover trial comparing ammonia control, assessed as 2

73 We conducted a double-blind crossover trial comparing gabapentin (up to 900 mg/day)

74 were evaluated in a prospective, randomized, crossover trial comparing hypoxia (17% FIO(2)) with hype

75 Proof-of-concept, randomized, double-blind, crossover trial comparing ketamine with an active placeb

76 A quasi-experimental, crossover trial comparing PPA and PPRF for adult inpatie

77 ecord-embedded, cluster-randomized, multiple-crossover trial comparing saline with balanced crystallo

78 The study was a randomized crossover trial, comparing intervention (0.5-1.0 micro T

79 tudy was a double-blind, placebo-controlled, crossover trial conducted in children and young adults a

80 Patients in the crossover trial continued to receive divalproex sodium.

81 ted using a double-blind, placebo-controlled crossover trial, counterbalanced for order.

82 MIP-1072 and (123)I-MIP-1095 2 wk apart in a crossover trial design.

83 We conducted a double-blind, randomized, crossover trial designed to detect a small effect of tre

84 es of separate single-blind, Sham-controlled crossover trials, each including 24 healthy older adults

85 Of these, five crossover trials, enrolling a total of 71 patients (63 a

86 andomized, double-blind, placebo-controlled, crossover trial evaluating the pharmacodynamic effects o

87 In a randomized crossover trial, fasting plasma samples were obtained fr

88 A randomized, double-blind crossover trial for two successive painful procedures (b

89 A phase 2 randomized, placebo-controlled, crossover trial found that the GABA-B agonist arbaclofen

90 , double-blind, placebo-controlled, 3-period crossover trial, healthy adult men (n = 21) consumed bar

91 ouble-blind, placebo-controlled, two-period, crossover trial in 11 allergic asthmatic patients.

92 double-blind, placebo-controlled, two-period crossover trial in 12 subjects with mild-to-moderate ast

93 double-blind, randomized, placebo-controlled crossover trial in 18 adults with DSM-5 SAD and compared

94 We performed a random-order, double-blind, crossover trial in 20 patients with exercise-induced ast

95 We conducted a randomized, double-blind, crossover trial in 24 postmenopausal women, each of whom

96 andomized, double-blind, placebo-controlled, crossover trial in 75 men and women with coronary artery

97 A randomized crossover trial in 9 healthy ileostomy participants was

98 This was a 3-period randomized crossover trial in free-living healthy individuals who c

99 Acute effects were assessed in a crossover trial in normal subjects (single dose of 25 mg

100 This was a randomized crossover trial in pregnant women (26-28 wk of gestation

101 ouble-blind, randomised, placebo-controlled, crossover trial in two UK medical centres.

102 We designed a crossover trial in which 24 men, 23 premenopausal women,

103 ts initially entered a 24-week, double-blind crossover trial in which fluphenazine and placebo were a

104 n study 3, an open-label, placebo-controlled crossover trial, in 12 men with mild-to-moderate COPD.

105 Our original study was a crossover trial including 19 otherwise healthy smokers w

106 andomized, double-blind, placebo-controlled, crossover trial including 20 high-functional adult males

107 Randomized, double-blind, treat-to-target crossover trial including two 32-week treatment periods,

108 In a three-way, double-blind, triple-dummy crossover trial involving 210 patients with asthma, we e

109 The second study was a crossover trial involving 22 subjects with hereditary an

110 andomized, placebo-controlled, double-blind, crossover trial involving 51 patients with OSA living be

111 Nonrandomized crossover trial involving 6 healthy adults who were trea

112 In this phase II randomised crossover trial, low-dose fish oil was effective in redu

113 subjects who entered the placebo-controlled crossover trial, mixed amphetamine salts was significant

114 ) double-blind, placebo-controlled inpatient crossover trial (N=54) and the multicenter outpatient Cl

115 e randomized double-blind placebo-controlled crossover trial of 14 female patients (median age 52 [30

116 els of hs-CRP in a randomized, double-blind, crossover trial of 22 patients with combined hyperlipide

117 ty-three adults participated in a randomized crossover trial of 3 controlled feeding phases of 25 d e

118 andomized, double-blind, placebo-controlled, crossover trial of 3 QT-prolonging drugs with 15 time-ma

119 Therefore, we performed a randomized crossover trial of 8 weeks of CPAP and 8 weeks of MRS tr

120 andomised, placebo-controlled, double-blind, crossover trial of a quadpill-a single capsule containin

121 ndertook a double-blind, placebo-controlled, crossover trial of acute tryptophan depletion using func

122 andomized, placebo-controlled, double-blind, crossover trial of clarithromycin 500mg with breakfast a

123 a double-blind placebo-controlled randomized crossover trial of folic acid at 5 mg/m2 in 25 normotens

124 We did a randomised crossover trial of glicazide and metformin in 36 patient

125 213 study is the first randomised controlled crossover trial of ileal bile acid transporter inhibitor

126 e performed a phase II randomised controlled crossover trial of low-dose and high-dose fish oil in pa

127 andomized, placebo-controlled, double-blind, crossover trial of oral glucosamine at standard doses (5

128 A double-blind randomized placebo-controlled crossover trial of propranolol in patients with mild-to-

129 blinded randomized controlled within-subject crossover trial of tight (80-110 mg/dL) vs. loose (120-1

130 randomized, double-blind, placebo-controlled crossover trials, one involving 42 subjects with hypokal

131 In a randomized crossover trial, patients with type 1 diabetes and norma

132 ouble-blind, randomised, placebo-controlled, crossover trial (ReBUILD) in patients with relapsing mul

133 Unknown generalizability to uncontrolled or crossover trial results.

134 a randomized double-blind placebo-controlled crossover trial, SC-51 was administered as a single oral

135 andomized, double-blind, placebo-controlled, crossover trial (September 2004-March 2007) involving 30

136 ensitivity analyses according to presence of crossover, trial size, and dacarbazine dose.

137 an unmasked, cluster-randomised, two-period crossover trial, ten paediatric intensive-care units at

138 ouble-blind, placebo-controlled, randomized, crossover trial that compared a transdermal patch of ABT

139 randomized, double-blind, placebo-controlled crossover trial that investigated the safety and toxicit

140 olled in separate randomized, double-masked, crossover trials that compared a 3-wk high-palmitic acid

141 In study 4, a placebo-controlled crossover trial, the effect of RPL554 (0.018 mg/kg) on l

142 We examined, in a four-period crossover trial, the influence of metformin (2,000 mg/da

143 We did a randomised controlled crossover trial to compare the efficacy of active OIT (u

144 randomized, double-blind, placebo-controlled crossover trial to determine if mixed amphetamine salts

145 multicenter, cluster-randomized, nonblinded crossover trial to evaluate the effect of daily bathing

146 lemia were enrolled in a placebo-controlled, crossover trial to evaluate the effect of transdermal es

147 , double-blind, placebo-controlled, phase 3, crossover trial to evaluate the efficacy and safety of i

148 randomized, double-blind, placebo-controlled crossover trial to investigate the effect of atorvastati

149 We conducted a double-blind, randomized, crossover trial to investigate the efficacy of midodrine

150 mized in a double-blind, placebo-controlled, crossover trial to receive incremental 90-minute infusio

151 domised, double-blinded, placebo-controlled, crossover trial to test whether intake of artificial foo

152 We conducted an open-label crossover trial to test whether proton pump inhibitors (

153 ses showed significant improvement in EF for crossover trials, trials with treatment duration </=12 w

154 randomized, double-blind, placebo-controlled crossover trial using enalapril (0.2 to 0.3 mg x kg[-1]

155 To pilot a cluster-randomized, multiple-crossover trial using software tools within the electron

156 A randomized crossover trial was conducted in 22 young, healthy, norm

157 This open-label, cluster, crossover trial was done in two Ghanaian non-tertiary ho

158 A single blind randomized crossover trial was performed comparing placebo (PL); lo

159 In a double-blind, randomized, crossover trial we sought to evaluate the effect of dual

160 a double-blind randomized placebo-controlled crossover trial, we administered a mild inflammatory sti

161 In a randomized, placebo-controlled, crossover trial, we administered testosterone cypionate

162 this multicenter, multinational, randomized, crossover trial, we assessed the short-term safety and e

163 In this randomized crossover trial, we compared the effects of 1 month each

164 inded, balanced, randomized, sham-controlled crossover trial, we determined the effect of a single-se

165 In this double-blind, placebo-controlled, crossover trial, we enrolled patients aged 18-79 years w

166 In this randomized controlled crossover trial, we investigated the effects of intranas

167 In a randomised, double-blind, crossover trial, we recruited eligible patients (severe

168 In this randomised, controlled, crossover trial, we recruited healthy volunteers (aged 2

169 In a randomised crossover trial, we screened 218 patients with chronic f

170 ind, placebo-controlled, randomized, two-way crossover trials were undertaken.

171 conducted a placebo-controlled, randomized, crossover trial where, after a 1 week baseline period, p

172 onducted a placebo-controlled, double-blind, crossover trial with 10 healthy participants.

173 We conducted a randomized, double-blind crossover trial with 3 intervention phases among 352 adu

174 weekly or placebo in a double-blind, partial-crossover trial with a second random assignment at year

175 In a cluster-randomized, crossover trial with strategies rotated in 4-month perio

176 andomized, double-blind, placebo-controlled, crossover trial with three study periods.

177 -40 y of age) were recruited in a randomized crossover trial with two 14-d isoenergetic diet periods

178 andomized, double-blind, placebo-controlled, crossover trial with two treatment periods each of two w